Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 4,278.24%99.61M | ---- | 101.13%2.28M | ---- | 57.98%-200.88M | ---- | -78.62%-478.12M | ---214.12M | -47.44%-267.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -35.76%-26.43M | ---- | -212.05%-19.47M | ---- | -80.21%-6.24M | ---- | -27.42%-3.46M | ---1.75M | 11.21%-2.72M |
| Impairment and provisions: | ---- | -63.05%4.54M | ---- | 46.81%12.29M | ---- | 78.77%8.37M | ---- | -32.04%4.68M | ---16K | 180.61%6.89M |
| -Impairment of property, plant and equipment (reversal) | ---- | -83.14%1.69M | ---- | 23.45%10.05M | ---- | 75.60%8.14M | ---- | -29.84%4.64M | ---- | 197.43%6.61M |
| -Impairmen of inventory (reversal) | ---- | 89.92%2.21M | ---- | --1.16M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -40.59%641K | ---- | 367.10%1.08M | ---- | 391.49%231K | ---- | -83.39%47K | ---16K | 20.94%283K |
| Revaluation surplus: | ---- | ---- | ---- | -6,522.55%-119.33M | ---- | -99.08%1.86M | ---- | 1,344.77%201.3M | --83.38M | --13.93M |
| -Other fair value changes | ---- | ---- | ---- | -6,522.55%-119.33M | ---- | -99.08%1.86M | ---- | 1,344.77%201.3M | --83.38M | --13.93M |
| Asset sale loss (gain): | ---- | -17.21%6.64M | ---- | 53.19%8.02M | ---- | 121.59%5.23M | ---- | 198.23%2.36M | --683K | -46.23%792K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -17.21%6.64M | ---- | 53.19%8.02M | ---- | 121.59%5.23M | ---- | 198.23%2.36M | --683K | -46.23%792K |
| Depreciation and amortization: | ---- | 27.44%569.89M | ---- | 24.63%447.18M | ---- | 18.13%358.8M | ---- | 23.69%303.74M | --144.28M | 27.59%245.57M |
| -Amortization of intangible assets | ---- | 5.83%54.1M | ---- | 7.69%51.13M | ---- | 10.33%47.48M | ---- | 7.02%43.03M | --20.84M | 11.35%40.21M |
| Financial expense | ---- | 13.80%80.28M | ---- | -13.65%70.54M | ---- | -8.76%81.69M | ---- | 41.89%89.53M | --41.95M | 19.93%63.1M |
| Special items | ---- | -26.00%67.44M | ---- | 138.94%91.14M | ---- | -55.96%38.14M | ---- | 160.86%86.61M | --46.73M | 271.72%33.2M |
| Operating profit before the change of operating capital | ---- | 62.79%801.96M | ---- | 71.67%492.64M | ---- | 38.88%286.97M | ---- | 121.98%206.64M | --101.14M | 26.96%93.09M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -470.41%-43.43M | ---- | 74.93%-7.61M | ---- | -180.09%-30.36M | ---- | -136.32%-10.84M | ---2.3M | 17.75%-4.59M |
| Accounts receivable (increase)decrease | ---- | -124.41%-3.3M | ---- | 61.49%-1.47M | ---- | -301.26%-3.82M | ---- | 29.17%-952K | ---15K | -227.03%-1.34M |
| Accounts payable increase (decrease) | ---- | 42.39%180.8M | ---- | 97.83%126.98M | ---- | -50.43%64.19M | ---- | 224.73%129.49M | --51.54M | -41.39%39.88M |
| prepayments (increase)decrease | ---- | -30.76%-58.34M | ---- | -670.94%-44.61M | ---- | 6.05%7.81M | ---- | 127.52%7.37M | --8.49M | -129.34%-26.78M |
| Special items for working capital changes | ---- | 32.65%18.19M | ---- | 58.60%13.71M | ---- | 27.91%8.65M | ---- | 105.78%6.76M | --4.99M | 502.08%3.29M |
| Cash from business operations | 5.09%440.38M | 54.56%895.89M | 108.34%419.07M | 73.84%579.64M | 3.79%201.15M | -1.48%333.44M | 18.28%193.8M | 226.88%338.46M | --163.85M | -16.73%103.54M |
| Other taxs | -87.50%-79.23M | -77.89%-77.47M | -60.12%-42.26M | -23.63%-43.55M | -0.64%-26.39M | -452.72%-35.23M | -311.47%-26.22M | ---6.37M | ---6.37M | ---- |
| Net cash from operations | -4.16%361.15M | 52.67%818.42M | 115.62%376.81M | 79.77%536.09M | 4.29%174.76M | -10.20%298.21M | 6.41%167.57M | 220.73%332.09M | --157.48M | -16.73%103.54M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -33.29%9.37M | 106.05%25.29M | 137.93%14.05M | 264.51%12.27M | 563.26%5.9M | 81.02%3.37M | -11.71%890K | 60.48%1.86M | --1.01M | -27.29%1.16M |
| Decrease in deposits (increase) | ---- | 200.99%432.44M | --432.44M | ---428.19M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | -5.00%19K | --127K | --20K | ---- | ---- | ---- | ---- | -75.30%1.21M | --894K | --4.9M |
| Purchase of fixed assets | -37.52%-174.06M | -29.74%-373.16M | -31.75%-126.57M | -47.33%-287.62M | -57.07%-96.07M | -14.31%-195.23M | 26.80%-61.16M | -33.84%-170.78M | ---83.56M | 17.77%-127.6M |
| Purchase of intangible assets | -20.36%-25.11M | -50.74%-43.08M | -52.78%-20.87M | -85.92%-28.58M | -73.58%-13.66M | -9.57%-15.37M | -0.83%-7.87M | 54.55%-14.03M | ---7.8M | -11.62%-30.86M |
| Net cash from investment operations | -163.46%-189.78M | 105.68%41.61M | 388.06%299.07M | -253.28%-732.12M | -52.36%-103.82M | -14.03%-207.23M | 23.83%-68.14M | -19.25%-181.74M | ---89.46M | 15.90%-152.41M |
| Net cash before financing | -74.65%171.36M | 538.72%860.04M | 852.81%675.88M | -315.47%-196.04M | -28.66%70.94M | -39.49%90.98M | 46.20%99.43M | 407.68%150.35M | --68.01M | 14.09%-48.87M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --200M | ---- | ---- | ---- | ---- | --200M | --100M | ---- | ---- | 123.08%145M |
| Refund | ---200M | ---- | ---- | ---- | ---- | -500.00%-180M | -1,700.00%-180M | ---30M | ---10M | ---- |
| Issuing shares | -2.12%3.37M | -99.05%5.23M | -99.37%3.44M | --548.92M | --548.92M | ---- | ---- | 104.17%577.39M | --258.84M | 415,780.88%282.8M |
| Interest paid - financing | -12.30%-42.67M | -12.84%-77.41M | -15.91%-37.99M | -5.52%-68.6M | 6.75%-32.78M | -2.83%-65.01M | -12.63%-35.15M | -34.60%-63.22M | ---31.21M | -58.08%-46.97M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | -1,240.32%-24.5M | -1,395.76%-23.98M | 78.04%-1.83M | -17.18%-1.6M | 18.60%-8.32M | ---1.37M | ---10.23M |
| Other items of the financing business | -18.29%-13.93M | -19.38%-24.61M | -35.05%-11.78M | -102.72%-20.61M | -122.64%-8.72M | 88.15%-10.17M | 75.25%-3.92M | -248.93%-85.81M | ---15.83M | -13.62%-24.59M |
| Net cash from financing operations | -26.90%-222.19M | -275.98%-382.01M | -145.30%-175.09M | 196.66%217.08M | 302.15%386.54M | -192.42%-224.58M | -242.33%-191.22M | 4.03%242.99M | --134.34M | 411.40%233.57M |
| Effect of rate | -231.80%-1.64M | -81.45%4.04M | -95.43%1.24M | 2.74%21.75M | 125.35%27.17M | 255.92%21.17M | 516.10%12.06M | 154.22%5.95M | --1.96M | -733.03%-10.97M |
| Net Cash | -110.15%-50.83M | 2,171.79%478.03M | 9.47%500.79M | 115.75%21.04M | 598.42%457.47M | -133.96%-133.6M | -145.36%-91.79M | 112.95%393.33M | --202.35M | 240.05%184.7M |
| Begining period cash | 82.12%1.07B | 7.86%587.04M | 7.86%587.04M | -17.12%544.25M | -17.12%544.25M | 155.13%656.67M | 155.13%656.67M | 207.67%257.39M | --257.39M | -61.42%83.66M |
| Cash at the end | -6.65%1.02B | 82.12%1.07B | 5.85%1.09B | 7.86%587.04M | 78.33%1.03B | -17.12%544.25M | 24.96%576.94M | 155.13%656.67M | --461.7M | 207.67%257.39M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.